Live Breaking News & Updates on Meets Primary Endpoint With|Page 1

Stay updated with breaking news from Meets primary endpoint with. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ocuphire Announces Positive Topline Results from MIRA-3 Phase 3 FDA Registration Trial for Nyxol® in the Reversal of Mydriasis

Ocuphire Announces Positive Topline Results from MIRA-3 Phase 3 FDA Registration Trial for Nyxol® in the Reversal of Mydriasis - read this article along with other careers information, tips and advice on BioSpace ....

Corey Davis , Ocuphire Pharma , Iuvo Bioscience , Mina Sooch , Nyxol Development Plan , Oculos Development Services , Ocuphire Pharma Inc , Meets Primary Endpoint With , Subjects Returning , Baseline Pupil Diameter , Placebo Subjects , Trial Showing Substantial Benefit , Accelerating Reversal , Only Dilation Reversal Drop , Webcast Today , Development Plan , Next Steps , Mydriasis Market , Private Securities Litigation Reform Act , Cuphire Announces Positive Topline Results From Mira 3 Phase Fda Registration Trial For Nyxol In The Reversal Of Mydriasis ,